Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
seizures
Pharma
Results for UCB's Fintepla pave way for 3rd epileptic indication
UCB plans to file for regulatory approval of Fintepla to treat a third epileptic condition “as soon as possible,” the company said.
Kevin Dunleavy
Dec 8, 2025 11:19am
BMS JV sale, biotech debuts, possible deals—Fierce Pharma Asia
Sep 19, 2025 8:36am
SK eyes Xcopri expansion with phase 3 win in new seizure type
Sep 17, 2025 11:32am
SK starts ad campaign to drive patients to seizure drug Xcopri
May 20, 2025 10:59am
Dr. Reddy's, Sun and Zydus issue separate drug recalls in the US
Mar 17, 2025 11:52am
Marinus trims workforce by 45% after pair of clinical stumbles
Nov 13, 2024 11:26am
